US Broker Ratings

Legend Biotech Corporation (LEGN): Investor Outlook with a 278% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is captivating the attention of investors, particularly those with an appetite for risk and a focus on the healthcare sector. With..

Jazz Pharmaceuticals plc (JAZZ): Investor Outlook with a 32% Potential Upside and Strong Buy Ratings

Investors seeking promising opportunities in the biotech sector may find Jazz Pharmaceuticals plc (NASDAQ: JAZZ) particularly intriguing, given its robust product lineup and attractive valuation metrics...

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring an 84% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is drawing investor attention with its compelling growth potential. Operating within the Medical Instruments..

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook on a Biotech Leader with 60% Upside Potential

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is a prominent player in the biotechnology sector, specializing in the development and commercialization of therapies for life-threatening rare diseases. Based..

DaVita Inc. (DVA) Stock Analysis: A 30.78% Upside Potential in the Healthcare Sector

DaVita Inc. (NYSE: DVA), a leading provider in the healthcare industry, particularly in medical care facilities, has piqued investor interest with a potential upside of 30.78%...

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A Compelling 34% Upside Potential in the Biotech Space

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company specializing in therapies for metabolic dysfunction-associated steatohepatitis (MASH), has captured the attention of investors with its impressive growth..

Option Care Health, Inc. (OPCH) Stock Analysis: A 17% Potential Upside with Strong Buy Ratings

For investors looking to tap into the burgeoning healthcare sector, Option Care Health, Inc. (NASDAQ: OPCH) presents an intriguing opportunity. This Bannockburn, Illinois-based company is a..

DexCom, Inc. (DXCM) Stock Analysis: Exploring a 16.64% Upside Potential in the Growing Medical Devices Sector

DexCom, Inc. (DXCM) stands at the forefront of innovation in the healthcare sector, specifically within the medical devices industry. Headquartered in San Diego, California, DexCom is..

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a Potential 90.61% Upside for Investors

Vaxcyte, Inc. (NASDAQ: PCVX), a prominent player in the biotechnology sector, is making significant waves with its innovative approach to vaccine development. Based in San Carlos,..

Globus Medical, Inc. (GMED): Analyst Consensus and Growth Potential Highlight an 18% Upside

Globus Medical, Inc. (NYSE: GMED) stands out in the healthcare sector, particularly within the medical devices industry, as a company that continues to capture investor attention..

Quest Diagnostics Incorporated (DGX) Stock Analysis: Navigating Growth with a 6.57% Upside Potential

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, specializes in diagnostics and research. With its headquarters in Secaucus, New Jersey, the company..

Insulet Corporation (PODD) Stock Analysis: A Compelling 44.81% Upside Potential for Investors

Investors looking for growth opportunities in the healthcare sector should turn their attention to Insulet Corporation (NASDAQ: PODD), a leader in innovative insulin delivery systems. With..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with 23% Upside Potential

argenx SE (ARGX), a leading player in the biotechnology industry, is capturing investor attention with its impressive growth potential and strategic global presence. Headquartered in Amsterdam,..

Teleflex Incorporated (TFX) Stock Analysis: Robust Revenue Growth and a 23.84% Potential Upside Signal a Promising Investment Opportunity

Teleflex Incorporated (NYSE: TFX), a noteworthy player in the Healthcare sector, has garnered attention from investors due to its promising revenue growth and substantial upside potential...

Universal Health Services, Inc. (UHS) Stock Analysis: A Healthcare Leader with 24% Upside Potential

Universal Health Services, Inc. (NYSE: UHS) stands as a notable entity in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization..

HCA Healthcare, Inc. (HCA) Stock Analysis: Strong Buy Ratings and a Promising 8.24% Upside

HCA Healthcare, Inc. (HCA), a giant in the healthcare sector with a market capitalization of $114.25 billion, continues to be a compelling choice for investors looking..

Tempus AI, Inc. (TEM) Investor Outlook: Navigating a 46.97% Upside Amidst High Growth and Strategic Collaborations

Tempus AI, Inc. (TEM), a Chicago-based healthcare technology firm, has captured investor attention with its substantial market cap of $10.64 billion and a robust revenue growth..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Promising 199% Upside Potential for Biotech Investors

Telix Pharmaceuticals Limited (TLX), an Australian biotechnology company, is making waves in the healthcare sector with its innovative approach to radiopharmaceuticals. As a commercial-stage biopharmaceutical company,..

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: Strong Buy Ratings and Promising 15.71% Potential Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a key player in the biotechnology sector, is rapidly gaining attention in the investment community with its innovative approach to managing..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Promising 9.68% Upside in the Biotech Arena

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, is commanding attention with a market cap of $13.39 billion and a current trading..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds